Internal Medicine, Hematology & Oncology · New York, NY
NPI
1134399306
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
325 W 15th St
New York, NY, 10011
Phone (212) 604-6058
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
539 services
Medicare patients, 2024
172
Average age 73
Drug cost, 2024
$2.8M
1,862 prescriptions
Company payments, 2025
$20.56
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Theresa H Shao was code 99214 (office e&m - established), 282 times for 132 patients. In total Theresa H Shao billed 539 services in 7 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 282 | 132 | $73.95 | $21K |
| 99215 Office E&M - Established | Office | 200 | 57 | $114.13 | $23K |
| 99213 Office E&M - Established | Office | 23 | 19 | $52.49 | $1,207 |
| 99205 Office E&M - New | Office | 20 | 20 | $158.67 | $3,173 |
By year: 2022 $53K for 706 services; 2023 $55K for 641 services; 2024 $49K for 539 services.
Medicare prescription drug claims, 2024
In 2024, the drug Theresa H Shao prescribed most often to Medicare patients was Anastrozole, with 867 prescriptions and refills. In total Theresa H Shao wrote 1,862 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 867 | 1,571 | 173 | $9,706 |
| Alendronate Sodium Generic | 212 | 366 | 46 | $1,153 |
| Letrozole Generic | 148 | 241 | 27 | $1,502 |
| Lynparza Olaparib | 77 | 77 | Under 11 | $756K |
| Exemestane Generic | 73 | 117 | 14 | $6,830 |
| Tamoxifen Citrate Generic | 52 | 80 | Under 11 | $937 |
| Ibrance Palbociclib | 36 | 36 | Under 11 | $568K |
| Verzenio Abemaciclib | 31 | 31 | Under 11 | $469K |
| Gabapentin Generic | 29 | 35 | 11 | $195 |
| Kisqali Ribociclib Succinate | 26 | 26 | Under 11 | $365K |
| Eliquis Apixaban | 21 | 27 | Under 11 | $16K |
| Prochlorperazine Maleate Generic | 21 | 21 | 14 | $387 |
| Loperamide Loperamide Hcl | 20 | 20 | Under 11 | $321 |
| Ondansetron Odt Ondansetron | 20 | 20 | 13 | $110 |
| Dexamethasone Generic | 14 | 14 | Under 11 | $247 |
Brand drugs: 242 claims; generic drugs: 1,620 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Theresa H Shao $20.56 ($20.56 in general payments such as food, travel and fees) from 2 companies. The largest payer was Daiichi Sankyo Inc. with $20.56.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 1 | $20.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.